Hims & Hers Health, Inc. (HIMS): Price and Financial Metrics
HIMS Price/Volume Stats
| Current price | $11.88 | 52-week high | $17.16 |
| Prev. close | $11.90 | 52-week low | $5.65 |
| Day low | $11.59 | Volume | 3,456,200 |
| Day high | $12.05 | Avg. volume | 4,684,000 |
| 50-day MA | $13.44 | Dividend yield | N/A |
| 200-day MA | $9.09 | Market Cap | 2.55B |
HIMS Stock Price Chart Interactive Chart >
Hims & Hers Health, Inc. (HIMS) Company Bio
Hims & Hers Health, Inc. provides health care software solutions. The Company offers multi-specialty telehealth platform that connects consumers to licensed healthcare providers, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, and primary care. Hims & Hers Health serves customers in the United States.
Latest HIMS News From Around the Web
Below are the latest news stories about HIMS & HERS HEALTH INC that investors may wish to consider to help them evaluate HIMS as an investment opportunity.
Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and LossSAN FRANCISCO, December 04, 2023--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today unveiled Weight Loss by Hims & Hers, a comprehensive and customizable clinical approach specifically designed to help people achieve their individual weight-loss goals. The company also announced that Craig Primack, MD, FACP, FAAP, FOMA, a pioneer in the field of clinical obesity medicine, has joined the company as SVP of Weight Management. |
5 Telehealth Stocks That Have Nothing But UpsideNavigate the exciting world of telehealth with our curated list of top telehealth stocks. |
It Is Time To Buy Hims & Hers StockHims & Hers is a pharmaceutical marketing, product, and distribution firm with a telehealth component. |
2024’s Hidden Gems: 7 Small-Caps Set for Explosive GrowthSmall-cap stocks outperform larger companies on an indexed basis, but finding the best among them individually isn't always easy |
Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 OutlookSAN FRANCISCO, November 06, 2023--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today reported financial results for the third quarter ended September 30, 2023. |
HIMS Price Returns
| 1-mo | -27.25% |
| 3-mo | 32.89% |
| 6-mo | 95.39% |
| 1-year | 0.59% |
| 3-year | 4.03% |
| 5-year | N/A |
| YTD | 33.48% |
| 2023 | 38.85% |
| 2022 | -2.14% |
| 2021 | -55.14% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...